All Stories

DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts

In Monday’s trading, Pacific Biosciences and 10x Genomics each saw their stock prices dive by 13% to 14%, while Illumina has been recovering from being caught up in the tariff battle between the U.S. and China.

Feb 10, 2025 - 22:48
 0
DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts
In Monday’s trading, Pacific Biosciences and 10x Genomics each saw their stock prices dive by 13% to 14%, while Illumina has been recovering from being caught up in the tariff battle between the U.S. and China.
Read More

Tags:

Previous Article

43rd Annual JP Morgan Healthcare Conference 2025

Next Article

Georgia system opens $566M tower

Related Posts

Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect

Novo Nordisk adds pediatric data to bulging bag of evid...

Feb 9, 2025  0

Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline

Biogen pays Stoke $165M, bagging Dravet prospect to fir...

Feb 18, 2025  0

Volta Medical’s afib AI shows gains in cardiac ablation study

Volta Medical’s afib AI shows gains in cardiac ablation...

Feb 14, 2025  0